MRNY was created on 2023-10-23 by YieldMax. The fund's investment portfolio concentrates primarily on health care equity. MRNY seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options.